The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The role of adjuvant chemotherapy in early-stage high-grade uterine leiomyosarcoma: A retrospective review.
M. Klobocista
No relevant relationships to disclose
A. A. Yessaian
No relevant relationships to disclose
C. P. Morrow
No relevant relationships to disclose
L. Muderspach
No relevant relationships to disclose
H. Pham
No relevant relationships to disclose
Y. G. Lin
No relevant relationships to disclose
R. Sposto
No relevant relationships to disclose
L. Roman
No relevant relationships to disclose